ORGS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ORGS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-25), Orgenesis's share price is $0.504. Orgenesis does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.
The historical rank and industry rank for Orgenesis's Price-to-Owner-Earnings or its related term are showing as below:
During the past 13 years, the highest Price-to-Owner-Earnings of Orgenesis was 3.44. The lowest was 1.06. And the median was 2.68.
As of today (2024-04-25), Orgenesis's share price is $0.504. Orgenesis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.61. Therefore, Orgenesis's PE Ratio for today is At Loss.
As of today (2024-04-25), Orgenesis's share price is $0.504. Orgenesis's EPS without NRI for the trailing twelve months (TTM) ended in was $-2.40. Therefore, Orgenesis's PE Ratio without NRI for today is At Loss.
The historical data trend for Orgenesis's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orgenesis Annual Data | |||||||||||||||||||||
Trend | Nov14 | Nov15 | Nov16 | Nov17 | Nov18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Price-to-Owner-Earnings | Get a 7-Day Free Trial | - | - | - | - | - |
Orgenesis Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Price-to-Owner-Earnings | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Orgenesis's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Orgenesis's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Orgenesis's Price-to-Owner-Earnings falls into.
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Orgenesis's Price-to-Owner-Earnings for today is calculated as
Price-to-Owner-Earnings | = | Share Price | / | Owner Earnings per Share (TTM) |
= | 0.504 | / | -1.26 | |
= |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orgenesis (NAS:ORGS) Price-to-Owner-Earnings Explanation
For how to get Owner Earnings per Share (TTM), please click.
Thank you for viewing the detailed overview of Orgenesis's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.
Elliot Maltz | officer: Chief Financial Officer | C/O GELESIS, INC., 501 BOYLSTON ST., SUITE 6102, BOSTON MA 02116 |
Jacob Safier | 10 percent owner | C/O THE WOLFSON GROUP, ONE STATE STREET PLAZA 29TH FLOOR, NEW YORK NY 10004 |
Efrat Assa Kunik | officer: Chief Development Officer | C/O ORGENESIS INC., 20271 GOLDENROD LANE, GERMANTOWN MD 20876 |
David Sidransky | director | JOHNS HOPKINS UNIVERSITY, 720 RUTLAND AVENUE, BALTIMORE MD 21205 |
Mario Philips | director | C/O ATMI, INC, DANBURY CT 06810 |
Sarah Ferber | officer: Chief Scientific Officer | 17B HAHASKALA STREET, TEL AVIV L3 67890 |
Guy Yachin | director | 7 ORCHARD WAY N, POTOMAC MD 20854 |
Yaron Adler | director | 4 HA'NECHOSHET ST., RAMAT HA'CHAYAL, TEL AVIV L3 69710 |
Vered Caplan | officer: CEO | 20 HA'ETZEL STREET, PO BOX 9118 RAMAT EFAL, KIRYAT ONO L3 55280 |
Universite Libre De Bruxelles | 10 percent owner | AVENUE F, ROOSEVELT, 50, BRUSSELS C9 1050 |
Olivier Belenger | 10 percent owner | DIEWEG, 69, BRUSSELS C9 1070 |
Ii Sa Theodorus | 10 percent owner | ALLEE DE LA RECHERCHE, 12, BRUSSELS C9 1070 |
Sca Theodorus | 10 percent owner | ALLEE DE LA RECHERCHE, 12, BRUSSELS C9 1070 |
Denis Bedoret | officer: See Remarks | 48, RUE AUGUSTE PICCARD, GOSSELIES C9 6041 |
Ashish Nanda | director | 2301, 23RD FLOOR, TIFFANY TOWERS, CLUSTER W, JLT, DUBAI, UAE, DUBAI C0 4452 |
From GuruFocus
By sperokesalga sperokesalga • 05-18-2023
By Marketwired • 07-13-2023
By Marketwired • 08-11-2023
By sperokesalga sperokesalga • 05-30-2023
By GlobeNewswire • 10-31-2023
By sperokesalga sperokesalga • 02-23-2023
By sperokesalga sperokesalga • 05-19-2023
By GuruFocusNews GuruFocusNews • 01-18-2022
By Value_Insider Value_Insider • 12-20-2022
By Value_Insider Value_Insider • 11-07-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.